Results of a phase II trial with second-line cystemustine at 60mg/m 2 in advanced soft tissue sarcoma: A trial of the EORTC early clinical studies group

Author： Cure H.   Krakowski I.   Adenis A.   Tubiana N.   Kerbrat P.   Roche H.   Chevallier   Lentz M.A.   Fumoleau P.   Chollet P.  

Publisher： Elsevier

ISSN： 0959-8049

Source： European Journal of Cancer, Vol.34, Iss.3, 1998-02, pp. : 422-423

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Results of a Phase II Trial with Cystemustine in Advanced Malignant Melanoma. A Trial of the EORTC Clinical Screening Group

By Urosevic V.   Chollet P.   Adenis A.   Chauvergne J.   Fargeot P.   Roche H.   Kerbrat P.   Lentz M.A.   Fumoleau P.   Chevallier B.  

European Journal of Cancer, Vol. 32, Iss. 1, 1996-01 ,pp. : 181-182

Elsevier

Access to resources Recommend Favorite

Results of randomised studies of the EORTC Soft Tissue and Bone Sarcoma Group (STBSG) with two different ifosfamide regimens in first- and second-line chemotherapy in advanced soft tissue sarcoma patients

By van Oosterom A.T.   Mouridsen H.T.   Nielsen O.S.   Dombernowsky P.   Krzemieniecki K.   Judson I.   Svancarova L.   Spooner D.   Hermans C.   Van Glabbeke M.   Verweij J.   for the EORTC STBSG  

European Journal of Cancer, Vol. 38, Iss. 18, 2002-12 ,pp. : 2397-2406

Elsevier

Access to resources Recommend Favorite

Randomised phase II trial of pegylated liposomal doxorubicin (DOXIL(R)/CAELYX(R)) versus doxorubicin in the treatment of advanced or metastatic soft tissue sarcoma - a study by the EORTC Soft Tissue and Bone Sarcoma Group

By Judson I.   Radford J.A.   Harris M.   Blay J.-Y.   van Hoesel Q.   le Cesne A.   van Oosterom A.T.   Clemons M.J.   Kamby C.   Hermans C.   Whittaker J.   Donato di Paola E.   Verweij J.   Nielsen S.  

European Journal of Cancer, Vol. 37, Iss. 7, 2001-05 ,pp. : 870-877

Elsevier

Access to resources Recommend Favorite

Temozolomide in adult patients with advanced soft tissue sarcoma: a phase II study of the EORTC Soft Tissue and Bone Sarcoma Group

By Woll P.J.   Judson I.   Lee S.M.   Rodenhuis S.   Nielsen O.S.   Buesa J.M.   Lorigan P.C.   Leyvraz S.   Hermans C.   van Glabbeke M.   Verweij J.  

European Journal of Cancer, Vol. 35, Iss. 3, 1999-03 ,pp. : 410-412

Elsevier

Access to resources Recommend Favorite

Gemcitabine in advanced adult soft-tissue sarcomas. A phase II study of the EORTC Soft Tissue and Bone Sarcoma Group

By Svancarova L.   Blay J.Y.   Judson I.R.   van Hoesel Q.G.C.M.   van Oosterom A.T.   le Cesne A.   Keizer H.J.   Hermans C.   van Glabbeke M.   Verweij J.   Hogendoorn P.C.W.   Nielsen O.S.  

European Journal of Cancer, Vol. 38, Iss. 4, 2002-03 ,pp. : 556-559

Elsevier

Access to resources Recommend Favorite